BackgroundThe prevalence of signs and symptoms of temporomandibular disorders (TMD) increases during adolescence and adulthood. Few studies have examined TMD prevalence in Brazilian adolescents.AimTo investigate the prevalence of TMD in Brazilian adolescents.MethodsA representative population-based sample of 934 adolescents (10–14-years-old) was examined. TMD screening was performed using a questionnaire by the American Academy of Orofacial Pain. TMD diagnoses used research diagnostic criteria for temporomandibular disorders (RDC/TMD—Axis-I). Examinations were performed by a single calibrated examiner (kappa > 0.80).ResultsThe prevalence of TMD symptoms was 34.9%; the most frequently reported symptoms were headache and neck ache (20.9%), followed by joint sounds (18.5%). Myofascial pain was the most prevalent type (10.3%), followed by disc displacement with reduction (8.0%) and arthralgia (3.5%). There was a significant association between sex and TMD symptoms; prevalence was significantly higher in girls (RP = 1.37; 95% CI = 1.14–1.65; p = 0.001). Myofascial pain of TMD and displacement with reduction were more prevalent in girls (RP = 1.76; p = 0.007 and RP = 2.06; p = 0.004, respectively).ConclusionTMD symptoms were present in 34.9% of adolescents, with myofascial pain being the most prevalent type (10.3%). TMD was significantly more common in girls. Routine pediatric dental care should include a TMD screening.
Anxiety is strongly associated with TMD in adolescents. Presence of Class II or III is associated with higher prevalence of myofascial pain in adolescentsPLESAE check and approve the edit made in the article title.
The aim of this study was to evaluate whether genetic polymorphisms in AMELX, AMBN, ENAM, TFIP11, and TUFT1 genes are associated with dental fluorosis (DF). A total of 1,017 children from 2 Brazilian cohorts were evaluated. These populations lived in cities with fluoridation of public water supplies. DF was assessed in erupted permanent teeth using the modified Dean index. The polymorphisms rs946252, rs12640848, rs4694075, rs5997096, and rs4970957 were analyzed by real-time PCR from genomic DNA. Associations between DF, genotype, and allele distribution were evaluated using the χ2 test, with an alpha of 5%. The polymorphisms rs4694075, rs5997096, and rs4970957 in AMBN, TFIP11, and TUFT1 were associated with DF (p < 0.05). In conclusion, enamel matrix genes are associated with DF.
The aim of this cross-sectional study was to evaluate the impact of anxiety and quality of sleep on quality of life (QOL) in undergraduate dental students. A total of 141 students were enrolled. All were required to answer the following questionnaires: the State-Trait Anxiety Inventory (STAI) subscale state (S) (STAI-S); the Sleep Assessment Questionnaire (SAQ); and the simplified World Health Organization Quality of Life survey (WHO QOL-bref). The statistical analysis included univariate and bivariate analyses and Poisson regressions. The mean age of the participants was 22.9 (SD=5.2) years; 81.6% were women, and 37.6% studied during the morning shift. The mean STAI-S score was 50.3 (SD=9.4). Sleep problems, classified as "always" or "frequently", were reported by 11.3% and 18.4% of the sample, respectively. Quality of life had a mean score of 13.2 (SD=2.0). The STAI-S and SAQ scores showed a significant association with all WHOQOL-bref dimensions (p<0.05). Analyses performed using multivariate regression and the highest STAI-S score (RR=1.46, 95%CI=1.03-2.06) and SAQ (RR=1.39, 95%CI=1.02-1.90) demonstrated significant sleep problems, even when other variables were controlled to prevent confounding biases. In conclusion, the dental students evaluated showed high levels of anxiety and sleep disorders impacting on QOL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.